Acadia Pharmaceuticals | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
ALKERMES USD 146.5M 168.54M 2024-12
Alnylam Pharmaceuticals USD 490.35M 75.33M 2024-12
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Corcept Therapeutics USD 178.93M 745K 2024-12
Cytokinetics -160545000 81.19M 2024-09
Eisai JPY 170.21B 16.72B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Incyte USD 985.09M 111.22M 2025-03
J&J USD 14.6B 816M 2025-03
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Pfizer USD 11.12B 987M 2025-03
Prothena -59001000 66.45M 2024-09
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Acadia Pharmaceuticals Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.